Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide and Pazopanib in Advanced PNET
NCT01465659Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Dec 2011
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in Pancreatic neuroendocrine tumor (PanNET), sponsored by Northwestern University. Started Dec 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
Pancreatic neuroendocrine tumor (PanNET)
Beyond the preview
Go deeper on NCT01465659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01465659.